Agenus | Capital De Empréstimo





Capital De Empréstimo Alterar Data
AbbVie USD 62.97B 12M 2025-09
Agenus USD 23.6M 448K 2025-09
Amgen USD 50B 2.43B 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
CSL USD 10.69B 1.37B 2025-06
Dynavax Technologies USD 220.97M 214K 2025-09
Eli Lilly USD 40.87B 6.69B 2025-09
Gilead Sciences USD 22.14B 5M 2025-09
GlaxoSmithKline GBP 14.71B 186M 2025-12
Glaxosmithkline GBP 20.02B 4.72B 2025-09
Incyte USD 35.37M 3.61M 2025-09
Intrexon USD 0 198.67M 2024-06
J&J USD 39.41B 173M 2025-09
Jiangsu Hengrui CNY 51.42M 5.94M 2025-09
Karyopharm Therapeutics USD -0.93 0.67 2024-12
MacroGenics USD 70.26M 4K 2025-09
Merck EUR 10.45B 4.15B 2025-09
Merck USD 39.97B 6B 2025-09
Novartis USD 24.24B 174M 2025-09
Novavax USD 223.63M 187K 2024-09
Pfizer USD 57.41B 93M 2025-09
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Rigel Pharmaceuticals USD 0 0 2024-09
Sangamo BioSciences USD 0 0 2022-06
Veracyte USD 0 0 2025-03


Agenus Capital De Empréstimo - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.